Skip to main content

AMCP Nexus 2025 Posters Main banner

Cell and Gene Therapies

Cell and Gene Therapies

Type here to filter the list

(45) Coverage Practices and Pricing of FDA approved Gene Therapies in the United States
(46) Integrating Cell and Gene Therapies into Managed Care: An Analysis of U.S. Payer Insights
(47) Payer policies and access restrictions for CRISPR-based gene therapy in sickle cell disease and beta-thalassemia: A systematic review of U.S. coverage frameworks
(48) The impact of the Cell and Gene Therapy Access Model on state Medicaid coverage of sickle cell disease gene therapies
(49) Utilization management and coverage restrictions for gene therapies in rare pediatric diseases: a systematic review of U.S. payer policies from 2019 to 2025